|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1099 USD | +10.56% |
|
-8.42% | -16.11% |
| Market Cap | 31.67M 27.53M 25.63M 23.53M 44.43M 3.02B 45.12M 302M 119M 1.51B 119M 116M 5.05B | P/E 2027 * |
3.66x | P/E 2028 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 31.67M 27.53M 25.63M 23.53M 44.43M 3.02B 45.12M 302M 119M 1.51B 119M 116M 5.05B | EV / Sales 2027 * |
0.74x | EV / Sales 2028 * | 0.72x |
| Free-Float |
33.16% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Earth Science Tech, Inc.
| 1 day | +10.56% | ||
| 1 week | -8.42% | ||
| 1 month | -35.28% | ||
| 3 months | -21.56% | ||
| 6 months | -30.09% | ||
| Current year | -16.11% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.17 |
| Current year | 0.07 | | 0.2 |
| 1 year | 0 | | 0.24 |
| 3 years | 0 | | 0.33 |
| 5 years | 0 | | 0.33 |
| 10 years | 0 | | 3.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 47 | 13/02/2023 |
Ernesto Flores
DFI | Director of Finance/CFO | 41 | 04/03/2024 |
Mario Tabraue
PSD | President | 47 | 01/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Tabraue
BRD | Director/Board Member | 47 | 01/11/2021 |
Jeff Cazeau
BRD | Director/Board Member | 58 | 13/02/2023 |
Giorgio Saumat
CHM | Chairman | 47 | 01/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/07/25 | Buy | Chief Executive Officer | 50,000 | 0.0168% | ||
| 21/07/25 | Buy | Chief Executive Officer | 100,000 | 0.0336% | ||
| 08/07/25 | Buy | Director | 33,044 | 0.0111% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.56% | -8.42% | -42.16% | +46.53% | 31.67M | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | |
| Average | -0.19% | -1.92% | +22.89% | +49.43% | 357.38B | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.24% | +72.95% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.99M 37.37M 34.78M 31.93M 60.3M 4.1B 61.24M 410M 161M 2.04B 161M 158M 6.85B | 43.98M 38.23M 35.59M 32.67M 61.7M 4.2B 62.66M 419M 165M 2.09B 165M 162M 7.01B |
| Net income | - | 4.94 4.3 4 3.67 6.94 472.05 7.04 47.16 18.51 235.01 18.57 18.16 788.02 |
| Net Debt | - | - |
Employees
77
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $0.1099 | +10.56% | 18,206 |
| 30/07/26 | $0.0994 | -9.64% | 182,473 |
| 29/07/26 | $0.1100 | -.--% | 48,745 |
| 28/07/26 | $0.1100 | +2.80% | 100,179 |
| 27/07/26 | $0.1070 | -10.83% | 149,145 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ETST Stock
Select your edition
All financial news and data tailored to specific country editions
